A "hybrid" immune system approach may prevent or cure Type 1 diabetes (T1D) by combining blood stem cell and islet cell transplants. The method uses a nonmyeloablative conditioning regimen to prevent ...
Morning Overview on MSN
Stanford reverses type 1 diabetes in mice by immune reboot
Stanford scientists have taken a striking step toward reimagining type 1 diabetes treatment, using a carefully calibrated ...
A Stanford study confirmed a complete reversal of type 1 diabetes in mice through a combination of stem cell transplants and ...
HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of ...
Montreal, May 30, 2023—Researcher Guy Rutter and his colleagues in Europe, Canada and the United States have discovered molecules in samples taken from 3,000 diabetic patients that could help ...
Researchers have assembled the first reference genome for the Nile rat — a kind of genetic template of this species that may be used for laboratory and clinical studies. The hope, according to UC ...
In a recent study posted to bioRxiv*, researchers in the United States assessed the impact of metabolic diseases on coronavirus disease 2019 (COVID-19) vaccine immunogenicity in a mouse model. The ...
In the last issue of The Enrichment Record, Emily Patterson-Kane and I reported on the work (Cao, Liu et al.) in which investigators demonstrated that even short-term exposure to environmental ...
Researchers have assembled the first reference genome for the Nile rat -- a kind of genetic template of this species that may be used for laboratory and clinical studies. The hope is that it will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results